Stocks and Investing Stocks and Investing
Wed, November 9, 2022
Tue, November 8, 2022

Vikram Purohit Maintained (AXSM) at Hold with Decreased Target to $73 on, Nov 8th, 2022


Published on 2024-10-28 00:01:24 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Decreased Target from $74 to $73 on, Nov 8th, 2022.

Vikram has made no other calls on AXSM in the last 4 months.



There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Vikram


  • Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $72 on, Friday, October 14th, 2022
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
  • Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $76 on, Wednesday, September 7th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022

Contributing Sources